Nasdaq
CGTX
Cognition Therapeutics, Inc.
- Health Care
- Listed 2021
- 1 day
- +6.6%
- 1 month
- +4.6%
- 1 year
- +58.9%
$1.13 · Mkt cap $101M
At the 6 Aug 2026 close
Nasdaq
Cognition Therapeutics, Inc.
$1.13 · Mkt cap $101M
At the 6 Aug 2026 close
Cognition Therapeutics, Inc. trades under the ticker CGTX on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2021. Its market capitalisation is $101M. The last closing price was $1.13, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +58.9%, and +4.6% over the past month. Returns are price returns and exclude dividends.
This page exists because CGTX is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.